Harvard Bioscience (HBIO) Asset Utilization Ratio (2011 - 2026)
Harvard Bioscience (HBIO) posted quarterly Asset Utilization Ratio of 1.08 for Q1 2026, up 22.27% year-over-year from 0.89 in Q1 2025, and down 1.14% quarter-over-quarter from 1.1 in Q4 2025.
Harvard Bioscience (HBIO) Asset Utilization Ratio (2011 - 2026) Analysis & Trends
Harvard Bioscience (HBIO) has reported Asset Utilization Ratio for 16 consecutive years, with 1.08 the latest figure, recorded in Q1 2026.
- In Q1 2026, Asset Utilization Ratio rose 22.27% year-over-year to 1.08; the TTM figure through Mar 2026 stood at 1.08 (up 22.27% YoY), while the FY2025 annual figure was 0.84, up 17.43% from the prior year.
- Asset Utilization Ratio fell to 1.08 in Q1 2026 per HBIO's latest filing, from 1.1 in the prior quarter.
- Across five years, Asset Utilization Ratio topped out at 1.11 in Q2 2025 and bottomed at 0.73 in Q4 2024.
- Historically, Asset Utilization Ratio has averaged 0.86 across 5 years, with a median of 0.79 in 2024.
- Annual changes were most pronounced in 2024 — Asset Utilization Ratio slipped 9.89% — and 2025, when it jumped 50.01%.
- Harvard Bioscience's Asset Utilization Ratio stood at 0.78 in 2022, then increased by 4.5% to 0.81 in 2023, then fell by 9.89% to 0.73 in 2024, then jumped by 50.01% to 1.1 in 2025, then decreased by 1.14% to 1.08 in 2026.
- Business Quant data shows HBIO's Asset Utilization Ratio at 1.08 in Q1 2026, 1.1 in Q4 2025, and 1.11 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 0.54 |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 0.46 |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 0.34 |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 0.64 |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 0.73 |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 0.81 |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 0.59 |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 0.34 |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 0.56 |
| 10 | Harvard Bioscience | 33.45 Mn | 26.94 Mn | 12.63 Mn | 1.14 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.14 |
| Mar 31, 2026 | 1.08 |
| Dec 31, 2025 | 1.10 |
| Sep 30, 2025 | 1.11 |
| Jun 30, 2025 | 1.11 |
| Mar 31, 2025 | 0.89 |
| Dec 31, 2024 | 0.73 |
| Sep 30, 2024 | 0.75 |
| Jun 30, 2024 | 0.77 |
| Mar 31, 2024 | 0.79 |
| Dec 31, 2023 | 0.81 |
| Sep 30, 2023 | 0.80 |
| Jun 30, 2023 | 0.79 |
| Mar 31, 2023 | 0.79 |
| Dec 31, 2022 | 0.78 |
| Sep 30, 2022 | 0.78 |
| Jun 30, 2022 | 0.77 |
| Mar 31, 2022 | 0.75 |
| Dec 31, 2021 | 0.75 |
| Sep 30, 2021 | 0.76 |